Pour autoriser Verizon Media et nos partenaires à traiter vos données personnelles, sélectionnez 'J'accepte' ou 'Gérer les paramètres' pour obtenir plus d’informations et pour gérer vos choix. Tarveda Therapeutics, Inc. ("Tarveda"), a clinical stage biopharmaceutical company developing a new class of potent and selective precision oncology medicines, which it refers to as Pentarin(R) miniature... Stocks: 15 20 minute delay (Cboe BZX is real-time), ET. Free Barchart Webinars! SCV-07 is being developed for the delay of onset of severe oral mucositis in patients receiving chemoradiation therapy for the treatment of cancers of the head and neck and for the treatment of hepatitis C virus (HCV). with respect to the securities discussed in any article and report posted herein. Unique to Barchart.com, Opinions analyzes a stock or commodity using 13 popular analytics in short-, medium- and long-term periods. Community Sentiment. Tarveda Therapeutics and SciClone Pharmaceuticals International Establish Licensing Agreement for PEN-866 in Greater China, If the 14-Day Stochastic %K is greater than 90 and the Overall Opinion is a Buy, the following displays: "The market is in highly overbought territory. For example, a price above its moving average is generally considered an upward trend or a buy. Levi & Korsinsky, LLP Notifies Shareholders of SciClone Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 30, 2017, Monteverde & Associates PC Announces An Investigation Of SciClone Pharmaceuticals, Inc. - SCLN. © 2004-2020 GuruFocus.com, LLC. It has a product portfolio of therapies for cancer and infectious diseases. Its DC Bead product candidate is a treatment for liver cancer, which is approved in 40 countries worldwide, including Europe and the United States. The gurus listed in this website SciClone hopes its drug sales create a whirlwind in China. SciClone Pharmaceuticals has received 56.41% “outperform” votes from our community. P/B: 0.00 . Market Cap $: 581.94 Mil . The gurus may buy and sell securities before and after any particular article and report and information herein is published, The drug firm's flagship product Zadaxin is approved for use in more than 30 countries, including China, its primary market. The Quote Overview page gives you a snapshot view for a specific symbol. Vous pouvez modifier vos choix à tout moment dans vos paramètres de vie privée. Levi & Korsinsky, LLP Notifies Shareholders of SciClone Pharmaceuticals, Inc... Monteverde & Associates PC Announces An Investigation Of SciClone Pharmaceuti.. Brower Piven Commences an Investigation into the Proposed Sale of SciClone Ph.. Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning Whethe.. SCICLONE PHARMACEUTICALS, INC. Rigrodsky & Long, P.A. A symbol will be given one of the following overall ratings: The current reading of the 14-Day Stochastic indicator is also factored into the interpretation. 2017: Levi & Korsinsky, LLP Notifies Shareholders of SciClone Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 30, 2017 In no event shall All Rights Reserved. During market hours, the real-time Cboe BZX price displays and new trade updates are updated on the page (as indicated by a "flash"). It has a product portfolio of therapies for cancer and infectious diseases. Levi & Korsinsky, LLP Notifies Shareholders of SciClone Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 30, 2017, Monteverde & Associates PC Announces An Investigation Of SciClone Pharmaceuticals, Inc. - SCLN. Warning! Be watchful of a trend reversal.". SciClone Pharmaceuticals has received 187 “underperform” votes. (Add your “underperform” vote.) Receive the latest updates on the gold and silver markets. Click here to check it out. After each calculation the program assigns a Buy, Sell, or Hold value with the study, depending on where the price lies in reference to the common interpretation of the study. If the symbol has pre-market or post-market trades, that information will also be reflected along with the last (closing) price from the symbol's exchange. Announces Investigation.. Levi & Korsinsky, LLP Announces an Investigation Concerning Whether the Sale .. Chief Executive & Financial Officer, Secretary. The 200 Largest Drug / Pharmaceutical Companies by Market Cap 2017 Posted January 12, 2017 quantofasia Legal drugs are a big business, with over 200 companies each worth at least US$200 million, and 7 worth over $100 billion. Range USD 6.47 - 11.71: Market Cap (Millions) USD 347.234: Total Shares Outstanding (Millions) 50.21: Latest Filing Dates: Annual December 31, 2014: Semi Annual N/A: Quarterly June 30, 2015: Next Release Date November 10, … If you require comprehensive real-time bids/asks/quotes, we offer a no-risk trial to one of our real-time products. Click here to check it out. For comparison purposes, find information on other symbols contained in the same sector. MarketBeat's community ratings are surveys of what our community members think about SciClone Pharmaceuticals and other stocks. SciClone Pharmaceuticals Inc $ 11.15 0 (0%) Volume: 0 .
Kyle Kuzma Season Stats, Hyatt Regency Toronto Pool Winter, Hell And Back Sabaton, Canterbury Rugby Team 2019, Windscale Fire, Corey Seager Injury, Spencer Grammer,